PetIQ, Inc. - (PETQ): Price and Financial Metrics
PetIQ, Inc. - (PETQ)
Today's Latest Price: $29.28 USD
Updated Dec 2 4:00pm
Add PETQ to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
PETQ Stock Summary
- PETQ's went public 3.37 years ago, making it older than merely 11.32% of listed US stocks we're tracking.
- Of note is the ratio of PetIQ Inc's sales and general administrative expense to its total operating expenses; 84.12% of US stocks have a lower such ratio.
- Over the past twelve months, PETQ has reported earnings growth of -196.46%, putting it ahead of just 10.22% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to PetIQ Inc, a group of peers worth examining would be USAP, CMT, DLA, FET, and AIRI.
- PETQ's SEC filings can be seen here. And to visit PetIQ Inc's official web site, go to www.petiq.com.
PETQ Stock Price Chart Interactive Chart >
PETQ Price/Volume Stats
| Current price | $29.28 | 52-week high | $38.99 |
| Prev. close | $29.06 | 52-week low | $15.83 |
| Day low | $28.44 | Volume | 236,605 |
| Day high | $29.39 | Avg. volume | 378,682 |
| 50-day MA | $30.20 | Dividend yield | N/A |
| 200-day MA | $29.76 | Market Cap | 840.25M |
PetIQ, Inc. - (PETQ) Company Bio
PetIQ, Inc. manufactures and distributes health and wellness products for dogs and cats. The Company offers pet prescription medications, over-the-counter flea and tick preventives, health and wellness supplements, and dog and cat treats. The company is based in Eagle, Idaho.
PETQ Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $29.28 | $406.25 | 1296% |
Below please find a table outlining a discounted cash flow forecast for PETQ, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that PetIQ Inc ranked in the 87th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of PetIQ Inc, consider:
- The company's balance sheet shows it gets 65% of its capital from equity, and 35% of its capital from debt. Notably, its equity weight is greater than only 18.86% of US equities in the Healthcare sector yielding a positive free cash flow.
- PetIQ Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.27. This coverage rate is greater than that of only 24.58% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 1268% |
| 1% | 1282% |
| 2% | 1296% |
| 3% | 1309% |
| 4% | 1323% |
| 5% | 1337% |
Want more companies with a valuation profile/forecast similar to that of PetIQ Inc? See AMS, USNU, SUPN, NHC, and ARGX.
Loading social stream, please wait...